494PA multi-institutional randomized phase II study on the timing of oxaliplatin plus 5-fluorouracil (FOLFOX) for patients (pts) with operable stage III rectal cancer: The KIR study. (23rd October 2018) - Kavan, P; Barrera, I; Azoulay, L; Martin, A-G; Vasilevsky, C; Boutros, M; Ferland, E; Batist, G; Vuong, T